Amoxicillin Potassium Clavulanate Oral Suspension IP is a medication used to treat bacterial infections. It contains two active ingredients: amoxicillin, a penicillin antibiotic, and potassium clavulanate, a beta-lactamase inhibitor. Amoxicillin kills bacteria by inhibiting their ability to form cell walls, while potassium clavulanate prevents the breakdown of amoxicillin by certain bacteria, enhancing its effectiveness. This combination medication is commonly prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other bacterial infections. The oral suspension form is often prescribed for children or individuals who have difficulty swallowing tablets. It is important to take the medication as prescribed and complete the full course to ensure effective treatment.
Amoxicillin Potassium Clavulanate Oral Suspension IP is a medication used to treat bacterial infections. It contains two active ingredients: amoxicillin, a penicillin antibiotic, and potassium clavulanate, a beta-lactamase inhibitor. Amoxicillin kills bacteria by inhibiting their ability to form cell walls, while potassium clavulanate prevents the breakdown of amoxicillin by certain bacteria, enhancing its effectiveness. This combination medication is commonly prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other bacterial infections. The oral suspension form is often prescribed for children or individuals who have difficulty swallowing tablets. It is important to take the medication as prescribed and complete the full course to ensure effective treatment.
MEDICLOCKHEALTHCARE.COM
Amoxicillin Potassium Clavulanate Oral Suspension IP
Product Name : Amoxicillin Potassium Clavulanate Oral Suspension IP Brand Name : MESACLAV DS | MESACLAV DUO | MESACLAV ES Strength : 400mg + 57mg | 200mg + 28.50mg |600mg + 42.9mg Manufacturer : Mediclock Healthcare Pvt. Ltd. Packing : 30ml | 50ml Production Capacity : 10 Million Suspension/Month
0 Comments 0 Shares 991 Views